Arbutus Biopharma Corporation Soared

Fri, Dec 20, 2019 at 06:48 PM
Arbutus Biopharma Corporation Soared

Arbutus Biopharma Corporation (ABUS:NASDAQ) rocketted at $2.89, representing a gain of 26.8%. On Thu 19 Dec 19, ABUS:NASDAQ touched a New 2-Week Intraday Low of $2.2.

About Arbutus Biopharma Corporation (ABUS:NASDAQ)

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.